BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. The Lancet Haematology 2016;3:e237-45. [DOI: 10.1016/s2352-3026(16)30018-7] [Cited by in Crossref: 113] [Cited by in F6Publishing: 40] [Article Influence: 18.8] [Reference Citation Analysis]
Number Citing Articles
1 Bonnefond S, Foucher A, Zunic P, Hoarau G, Magnaval JF. Atypical presentation of hepatic visceral larva migrans mimicking cancer and associated with ADAMTS13 deficiency-mediated thrombotic microangiopathy: A first report from Reunion Island. PLoS Negl Trop Dis 2017;11:e0005617. [PMID: 28727752 DOI: 10.1371/journal.pntd.0005617] [Reference Citation Analysis]
2 Knöbl P. Thrombotic thrombocytopenic purpura. Memo 2018;11:220-6. [PMID: 30220931 DOI: 10.1007/s12254-018-0429-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Nagalla S, Sarode R. Recent advances in understanding and management of acquired thrombocytopenia. F1000Res 2018;7:68. [PMID: 29399327 DOI: 10.12688/f1000research.12309.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Long B, Bridwell RE, Manchanda S, Gottlieb M. Evaluation and Management of Thrombotic Thrombocytopenic Purpura in the Emergency Department. J Emerg Med 2021;61:674-82. [PMID: 34518045 DOI: 10.1016/j.jemermed.2021.07.045] [Reference Citation Analysis]
5 Hanlon A, Metjian A. Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura. Ther Adv Hematol 2020;11:2040620720902904. [PMID: 32095224 DOI: 10.1177/2040620720902904] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
6 Louw S, Gounden R, Mayne ES. Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era. Thromb J 2018;16:35. [PMID: 30559606 DOI: 10.1186/s12959-018-0189-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Wendt R, Kalbitz S, Otto F, Falter T, Beige J, Rossmann H, Lämmle B. Diagnosis of Hereditary TTP Caused by Homozygosity for a Rare Complex ADAMTS13 Allele After Salmonella Infection in a 43-Year-Old Asylum Seeker. Front Med (Lausanne) 2021;8:639441. [PMID: 33732721 DOI: 10.3389/fmed.2021.639441] [Reference Citation Analysis]
8 Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P, Grange S, Halimi JM, Lautrette A, Delmas Y, Presne C, Hamidou M, Girault S, Pène F, Perez P, Kanouni T, Seguin A, Mousson C, Chauveau D, Ojeda-Uribe M, Barbay V, Veyradier A, Coppo P, Benhamou Y. Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre. Am J Hematol 2017;92:381-7. [PMID: 28133771 DOI: 10.1002/ajh.24665] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
9 Li JQ, Tian JM, Fan XR, Wang ZY, Ling J, Wu XF, Yang FY, Xia YL. miR-106b-5p induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura through NR4A3/Foxp3 pathway. Cell Cycle 2020;19:1265-74. [PMID: 32323598 DOI: 10.1080/15384101.2020.1746485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Azoulay E, Bauer PR, Mariotte E, Russell L, Knoebl P, Martin-Loeches I, Pène F, Puxty K, Povoa P, Barratt-Due A, Garnacho-Montero J, Wendon J, Munshi L, Benoit D, von Bergwelt-Baildon M, Maggiorini M, Coppo P, Cataland S, Veyradier A, Van de Louw A; Nine-i Investigators. Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med 2019;45:1518-39. [PMID: 31588978 DOI: 10.1007/s00134-019-05736-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
11 Oliveira DS, Lima TG, Benevides FLN, Barbosa SAT, Oliveira MA, Boris NP, Silva HF. Plasmic score applicability for the diagnosis of thrombotic microangiopathy associated with ADAMTS13-acquired deficiency in a developing country. Hematol Transfus Cell Ther 2019;41:119-24. [PMID: 31079658 DOI: 10.1016/j.htct.2018.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
12 Bae SH, Kim SH, Bang SM. Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura. Blood Res 2022;57:37-43. [PMID: 35483924 DOI: 10.5045/br.2022.2022005] [Reference Citation Analysis]
13 Jiang Y, Huang D, Kondo Y, Jiang M, Ma Z, Zhou L, Su J, Bai X, Ruan C, Wang Z, Xia L. Novel mutations in ADAMTS13 CUB domains cause abnormal pre-mRNA splicing and defective secretion of ADAMTS13. J Cell Mol Med 2020;24:4356-61. [PMID: 32073234 DOI: 10.1111/jcmm.15025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Fourmont AM, Zafrani L, Mariotte E, Galicier L, Joly B, Merceron S, Bertinchamp R, Lemiale V, de Jong A, Valade S, Darmon M, Veyradier A, Azoulay E. The clinical features of cardiac involvement in patients with severe thrombotic thrombocytopenic purpura. Intensive Care Med 2018;44:963-5. [PMID: 29752524 DOI: 10.1007/s00134-018-5216-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Alshamam MS, Sumbly V, Khan S, Nso N, Rizzo V. Acquired Thrombotic Thrombocytopenic Purpura in a Newly Diagnosed HIV Patient: A Case Report and Literature Review. Cureus 2021;13:e15967. [PMID: 34336459 DOI: 10.7759/cureus.15967] [Reference Citation Analysis]
16 Baysal M, Ümit E, Kırkızlar HO, Demir AM. Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia. Turk J Haematol 2021;38:64-8. [PMID: 33161686 DOI: 10.4274/tjh.galenos.2020.2020.0348] [Reference Citation Analysis]
17 Umapathi KK, Thavamani A, Puliyel M. Predictors of In-Hospital Mortality in Thrombotic Thrombocytopenic Purpura in Children in the United States: A Population Analysis. J Pediatr Hematol Oncol 2020;42:e340-4. [PMID: 32011563 DOI: 10.1097/MPH.0000000000001725] [Reference Citation Analysis]
18 Jamme M, Raimbourg Q, Chauveau D, Seguin A, Presne C, Perez P, Gobert P, Wynckel A, Provôt F, Delmas Y, Mousson C, Servais A, Vrigneaud L, Veyradier A, Rondeau E, Coppo P; French Thrombotic Microangiopathies Reference Centre. Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome. PLoS One 2017;12:e0177894. [PMID: 28542627 DOI: 10.1371/journal.pone.0177894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
19 Valade S, Joly BS, Veyradier A, Fadlallah J, Zafrani L, Lemiale V, Launois A, Stepanian A, Galicier L, Fieschi C, Mirouse A, Tudesq JJ, Lepretre AC, Azoulay E, Darmon M, Mariotte E. Coagulation disorders in patients with severe hemophagocytic lymphohistiocytosis. PLoS One 2021;16:e0251216. [PMID: 34343182 DOI: 10.1371/journal.pone.0251216] [Reference Citation Analysis]
20 Joseph A, Eloit M, Azoulay E, Kaplanski G, Provot F, Presne C, Wynckel A, Grangé S, Rondeau É, Pène F, Delmas Y, Lautrette A, Barbet C, Mousson C, Coindre J, Perez P, Jamme M, Augusto J, Poullin P, Jacobs F, El Karoui K, Vigneau C, Ulrich M, Kanouni T, Le Quintrec M, Hamidou M, Ville S, Charvet‐rumpler A, Ojeda‐uribe M, Godmer P, Fremeaux‐bacchi V, Veyradier A, Halimi J, Coppo P. Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12702] [Reference Citation Analysis]
21 Staley EM, Cao W, Pham HP, Kim CH, Kocher NK, Zheng L, Gangaraju R, Lorenz RG, Williams LA, Marques MB, Zheng XL. Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura. Haematologica 2019;104:166-75. [PMID: 30171022 DOI: 10.3324/haematol.2018.198275] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
22 Van de Louw A, Mariotte E, Darmon M, Cohrs A, Leslie D, Azoulay E. Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era. PLoS One 2021;16:e0256024. [PMID: 34383822 DOI: 10.1371/journal.pone.0256024] [Reference Citation Analysis]
23 Shi J, Huan X, Zhou L, Xi J, Song J, Wang Y, Luo S, Zhao C. Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese Cohort. Front Neurol 2021;12:790941. [PMID: 34880829 DOI: 10.3389/fneur.2021.790941] [Reference Citation Analysis]
24 Mancini I, Giacomini E, Pontiggia S, Artoni A, Ferrari B, Pappalardo E, Gualtierotti R, Trisolini SM, Capria S, Facchini L, Codeluppi K, Rinaldi E, Pastore D, Campus S, Caria C, Caddori A, Nicolosi D, Giuffrida G, Agostini V, Roncarati U, Mannarella C, Fragasso A, Podda GM, Birocchi S, Cerbone AM, Tufano A, Menna G, Pizzuti M, Ronchi M, De Fanti A, Amarri S, Defina M, Bocchia M, Cerù S, Gattillo S, Rosendaal FR, Peyvandi F. The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians. J Clin Med 2020;9:E3379. [PMID: 33096882 DOI: 10.3390/jcm9103379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 2020;18:2486-95. [PMID: 32914582 DOI: 10.1111/jth.15006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
26 Matthews A, Yui J, Chiang EY, Pishko AM, Cuker A, Cucchiara BL, George D, Sayani F, Mullen MT. Cerebral Infarction due to Severe ADAMTS-13 Deficiency with Normal Hematological Parameters: A Potentially Cause of Cryptogenic Stroke. J Stroke Cerebrovasc Dis 2022;31:106431. [PMID: 35305536 DOI: 10.1016/j.jstrokecerebrovasdis.2022.106431] [Reference Citation Analysis]
27 Al-Ahmad M, Al-Rasheed M, Shalaby NAB. Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine. EJHaem 2021. [PMID: 34226899 DOI: 10.1002/jha2.219] [Reference Citation Analysis]
28 Cines DB, Levine LD. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Program 2017;2017:144-51. [PMID: 29222249 DOI: 10.1182/asheducation-2017.1.144] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
29 Joly BS, Vanhoorelbeke K, Veyradier A. Understanding therapeutic targets in thrombotic thrombocytopenic purpura. Intensive Care Med 2017;43:1398-400. [PMID: 28116452 DOI: 10.1007/s00134-016-4662-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Colonne CK, Favaloro EJ, Pasalic L. The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer. Healthcare 2022;10:557. [DOI: 10.3390/healthcare10030557] [Reference Citation Analysis]
31 Coppo P, Cuker A, George JN. Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine. Res Pract Thromb Haemost 2019;3:26-37. [PMID: 30656273 DOI: 10.1002/rth2.12160] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
32 Graça NAG, Joly BS, Voorberg J, Vanhoorelbeke K, Béranger N, Veyradier A, Coppo P. TTP: From empiricism for an enigmatic disease to targeted molecular therapies. Br J Haematol 2022. [PMID: 35146746 DOI: 10.1111/bjh.18040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Zafrani L, Dekimpe C, Joly BS, Roose E, Fieux F, Azoulay E, Peraldi MN, Durrbach A, Coppo P, Vanhoorelbeke K, Veyradier A. Transfer of ADAMTS13 antibody-mediated thrombotic thrombocytopenic purpura via kidney transplantation. Haematologica 2019;104:e277-80. [PMID: 30819908 DOI: 10.3324/haematol.2019.219063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Renaud A, Caristan A, Seguin A, Agard C, Blonz G, Canet E, Eveillard M, Godmer P, Graveleau J, Lecouffe-Desprets M, Maisonneuve H, Perrin F, Hamidou M, Néel A. Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura. PLoS One 2021;16:e0260196. [PMID: 34797873 DOI: 10.1371/journal.pone.0260196] [Reference Citation Analysis]
35 Travert B, Rafat C, Mariani P, Cointe A, Dossier A, Coppo P, Joseph A. Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management. Toxins (Basel) 2021;13:306. [PMID: 33925836 DOI: 10.3390/toxins13050306] [Reference Citation Analysis]
36 Sukumar S, Gavriilaki E, Chaturvedi S. Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship. Thrombosis Update 2021;5:100062. [DOI: 10.1016/j.tru.2021.100062] [Reference Citation Analysis]
37 Shah J, Mandavdhare HS, Birda CL, Dutta U, Sharma V. Thrombotic thrombocytopenic purpura: A rare complication of acute pancreatitis. JGH Open 2019;3:435-7. [PMID: 31633051 DOI: 10.1002/jgh3.12156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Chiasakul T, Cuker A. Clinical and laboratory diagnosis of TTP: an integrated approach. Hematology Am Soc Hematol Educ Program 2018;2018:530-8. [PMID: 30504354 DOI: 10.1182/asheducation-2018.1.530] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
39 Hrdinová J, D'Angelo S, Graça NAG, Ercig B, Vanhoorelbeke K, Veyradier A, Voorberg J, Coppo P. Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers. Haematologica 2018;103:1099-109. [PMID: 29674502 DOI: 10.3324/haematol.2016.151407] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
40 Park YH. Diagnosis and management of thrombocytopenia in pregnancy. Blood Res 2022;57:79-85. [PMID: 35483931 DOI: 10.5045/br.2022.2022068] [Reference Citation Analysis]
41 Tiscia G, Sartori MT, Giuffrida G, Ostuni A, Cascavilla N, Nicolosi D, Battista C, Santeramo TM, Melillo L, Giordano G, Cappucci F, Fischetti L, Chinni E, Tarantini G, Cerbo A, Bertomoro A, Fabris F, Grandone E. Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers. J Clin Med 2021;10:5702. [PMID: 34884404 DOI: 10.3390/jcm10235702] [Reference Citation Analysis]
42 Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv 2017;1:590-600. [PMID: 29296701 DOI: 10.1182/bloodadvances.2017005124] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 19.4] [Reference Citation Analysis]
43 Pereira LCV, Ercig B, Kangro K, Jamme M, Malot S, Galicier L, Poullin P, Provôt F, Presne C, Kanouni T, Servais A, Benhamou Y, Daguindau N, Vanhoorelbeke K, Azoulay E, Veyradier A, Coppo P. Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura. Hemasphere 2020;4:e462. [PMID: 32885148 DOI: 10.1097/HS9.0000000000000462] [Reference Citation Analysis]
44 Subhan M, Scully M. Advances in the management of TTP. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
45 Xu X, Zhu T, Wu D, Zhang L. Sjögren’s syndrome initially presented as thrombotic thrombocytopenic purpura in a male patient: a case report and literature review. Clin Rheumatol 2018;37:1421-6. [DOI: 10.1007/s10067-017-3912-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
46 Mopuru R, Chaturvedi S, Burkholder BM. Relapsing Thrombotic Thrombocytopenic Purpura (TTP) in a Patient Treated with Infliximab for Chronic Uveitis. Ocul Immunol Inflamm 2020;:1-3. [PMID: 32945712 DOI: 10.1080/09273948.2020.1797117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Wu X, Wang L, Sun L, Li T, Ran X. Analysis of clinical effects and mechanism of recombinant human interleukin-11 with glucocorticoids for treatment of idiopathic thrombocytopenic purpura. Exp Ther Med 2017;13:519-22. [PMID: 28352325 DOI: 10.3892/etm.2016.3989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Ramachandran P, Erdinc B, Abowali HA, Zahid U, Gotlieb V, Spitalewitz S. High Incidence of Thrombotic Thrombocytopenic Purpura Exacerbation Rate Among Patients With Morbid Obesity and Drug Abuse. Cureus 2021;13:e14656. [PMID: 34055510 DOI: 10.7759/cureus.14656] [Reference Citation Analysis]
49 Schelpe AS, Roose E, Joly BS, Pareyn I, Mancini I, Biganzoli M, Deckmyn H, Voorberg J, Fijnheer R, Peyvandi F, De Meyer SF, Coppo P, Veyradier A, Vanhoorelbeke K. Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients. Haematologica 2019;104:1268-76. [PMID: 30523052 DOI: 10.3324/haematol.2018.205666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
50 Maqsood MH, Rubab K, Maqsood MZ. Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Cureus 2019;11:e5263. [PMID: 31576256 DOI: 10.7759/cureus.5263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Fodil S, Zafrani L. Severe Thrombotic Thrombocytopenic Purpura (TTP) with Organ Failure in Critically Ill Patients. JCM 2022;11:1103. [DOI: 10.3390/jcm11041103] [Reference Citation Analysis]
52 Lemiale V, Valade S, Mariotte E. Unresponsive Thrombotic Thrombocytopenic Purpura (TTP): Challenges and Solutions. Ther Clin Risk Manag 2021;17:577-87. [PMID: 34113115 DOI: 10.2147/TCRM.S205632] [Reference Citation Analysis]
53 Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood 2017;130:2271-7. [PMID: 28637667 DOI: 10.1182/blood-2017-05-781971] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
54 Little DJ, Mathias LM, Page EE, Kremer Hovinga JA, Vesely SK, George JN. Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura. Kidney Int Rep 2017;2:1088-95. [PMID: 29270517 DOI: 10.1016/j.ekir.2017.06.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Sukumar S, Lämmle B, Cataland SR. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management. J Clin Med 2021;10:536. [PMID: 33540569 DOI: 10.3390/jcm10030536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
56 Halimi J, Thoreau B, von Tokarski F, Bauvois A, Gueguen J, Goin N, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Lemaignen A, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Frémeaux-bacchi V, Vigneau C, Bayer G, Fakhouri F. What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02672-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Huijbers MG, Plomp JJ, van der Maarel SM, Verschuuren JJ. IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders. Ann N Y Acad Sci 2018;1413:92-103. [PMID: 29377160 DOI: 10.1111/nyas.13561] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
58 Șalaru DL, Adam CA, Marcu DTM, Șimon IV, Macovei L, Ambrosie L, Chirita E, Sascau RA, Statescu C. Acute myocardial infarction and extensive systemic thrombosis in thrombotic thrombocytopenic purpura: A case report and review of literature. World J Clin Cases 2021; 9(27): 8104-8113 [PMID: 34621868 DOI: 10.12998/wjcc.v9.i27.8104] [Reference Citation Analysis]
59 Beranger N, Benghezal S, Joly BS, Capdenat S, Delton A, Stepanian A, Coppo P, Veyradier A. Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay. Res Pract Thromb Haemost 2021;5:81-93. [PMID: 33537532 DOI: 10.1002/rth2.12461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
60 Martin SD, McGinnis E, Smith TW. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center. Am J Clin Pathol 2021;156:1103-12. [PMID: 34160013 DOI: 10.1093/ajcp/aqab078] [Reference Citation Analysis]
61 Boesen EI, Kakalij RM. Autoimmune-mediated renal disease and hypertension. Clin Sci (Lond) 2021;135:2165-96. [PMID: 34533582 DOI: 10.1042/CS20200955] [Reference Citation Analysis]